Suboxone is not a benzodiazepine. It is an opioid-based medication used to treat opioid use disorder. The two drug classes work on entirely different systems in the brain, carry different risks, and fall under different controlled substance schedules. The confusion likely comes from the fact that Suboxone and benzodiazepines are frequently mentioned together in warnings about dangerous drug combinations.
What Suboxone Actually Is
Suboxone contains two active ingredients: buprenorphine and naloxone. Buprenorphine is a long-acting partial opioid receptor agonist, meaning it activates the same brain receptors that heroin and prescription painkillers target, but only partially. This partial activation reduces cravings and withdrawal symptoms without producing the full high of stronger opioids. Naloxone is a pure opioid receptor antagonist, included to discourage misuse by injection. If someone tries to inject Suboxone, the naloxone blocks opioid receptors and can trigger withdrawal.
The FDA has approved the buprenorphine-naloxone combination for both detoxification from opioids and ongoing maintenance therapy for opioid use disorder. It is also sometimes used off-label for chronic pain management. Under federal law, Suboxone is classified as a Schedule III controlled substance.
How Benzodiazepines Work Differently
Benzodiazepines target a completely different receptor system. While Suboxone acts on opioid receptors, benzodiazepines enhance the activity of GABA, the brain’s primary calming neurotransmitter. They increase how often chloride channels open in brain cells, making neurons less excitable. This produces sedation, muscle relaxation, and reduced anxiety. Common examples include alprazolam (Xanax), lorazepam (Ativan), diazepam (Valium), and midazolam. You can often recognize them by their generic name endings: “-zolam” or “-pam.”
Benzodiazepines are classified as Schedule IV controlled substances, one level below Suboxone’s Schedule III designation. They are prescribed primarily for anxiety disorders, insomnia, seizures, and muscle spasms. The two drug classes share almost nothing in terms of chemistry, receptor targets, or intended use.
Why the Two Are Often Mentioned Together
Suboxone and benzodiazepines come up in the same conversations because combining them is dangerous. Both drugs depress the central nervous system, and when taken together, they can slow breathing to life-threatening levels. The FDA requires a boxed warning noting that combining benzodiazepines with opioids (including buprenorphine) has resulted in severe respiratory depression and death.
Research into the specific interaction shows it is not simply one drug amplifying the other in a straightforward way. A study examining buprenorphine combined with diazepam in rats found that the respiratory depression resulted from a complex pharmacodynamic interaction, where each drug affected different aspects of breathing. Diazepam reduced the strength of diaphragm contractions when combined with buprenorphine, and the effects on breathing depth could only be reversed by blocking both opioid and benzodiazepine receptors simultaneously.
Fatal overdoses from mixing benzodiazepines with buprenorphine, particularly through intravenous use, remain a significant safety concern in clinical settings.
Benzodiazepine Use During Suboxone Treatment
Many people being treated for opioid use disorder also struggle with anxiety, which is where the overlap becomes a practical concern. Clinical guidelines strongly recommend considering alternatives to benzodiazepines for patients on buprenorphine. Expert panel guidance rated “consider alternatives to benzodiazepines” as one of its highest-consensus recommendations, and separately emphasized that patients should be strongly advised against self-medicating with benzodiazepines during treatment.
For anxiety that persists after a patient has stabilized on Suboxone, guidelines recommend medications with lower abuse potential, such as SSRIs or other antidepressants, along with evidence-based therapy like cognitive behavioral therapy. Benzodiazepine prescribing guidelines for anxiety disorders more broadly do not recommend them as first-line treatment, citing sedation, cognitive effects, dependence, and eventual loss of effectiveness.
That said, some patients enter opioid treatment already taking a prescribed benzodiazepine. In those cases, guidelines advise caution rather than abrupt discontinuation, since stopping benzodiazepines suddenly carries its own serious risks, including seizures. One study of patients receiving buprenorphine alongside a benzodiazepine prescription found that the combination was not associated with greater odds of emergency department visits for overdoses while patients remained active in treatment. However, those same patients had more than three times the odds of accidental injury compared to those not taking benzodiazepines, with the highest risk among women.
Naloxone Does Not Reverse Benzodiazepine Overdose
Because Suboxone contains naloxone, some people wonder whether it could help in a benzodiazepine overdose. It cannot. Naloxone only works on opioid receptors. It has no effect on the GABA receptors that benzodiazepines act on. Benzodiazepine overdoses require a different reversal agent entirely (flumazenil, used in hospital settings). The CDC notes that naloxone will not harm someone overdosing on non-opioid drugs, but it will not help either.
This distinction reinforces the fundamental difference between the two drug classes. Suboxone and benzodiazepines affect separate receptor systems, serve different medical purposes, and carry different risk profiles. They are not interchangeable, not related, and not safe to combine without close medical supervision.